We are live on ! Find out more
EPIX

ESSA Pharma

Delisted

EPIX was delisted on the 8th of October, 2025.

10 hedge funds and large institutions have $1.9M invested in ESSA Pharma in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.52% less ownership

Funds ownership: 1.7%1.18% (-0.52%)

9% less funds holding

Funds holding: 1110 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

64% less capital invested

Capital invested by funds: $5.24M → $1.9M (-$3.35M)

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
1
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
EAM
1
Eventide Asset Management
Massachusetts
$699K
CV
2
Clarus Ventures
Massachusetts
$615K
OFM
3
Omega Fund Management
Massachusetts
$492K
CIBC World Market
4
CIBC World Market
Ontario, Canada
$58K +$70.1K +10,050 New
Citadel Advisors
5
Citadel Advisors
Florida
$18K +$15.5K +2,228 +236%
VF
6
Virtu Financial
New York
$8K +$9.99K +1,432 New
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$3K -$112 -16 -3%
Morgan Stanley
8
Morgan Stanley
New York
$3K +$4.01K +575 New
AIC
9
AWM Investment Company
New York
-$792K -72,013 Closed
DM
10
Deerfield Management
New York
-$779K -70,812 Closed
ACP
11
Acuta Capital Partners
California
-$242K -22,100 Closed
UBS Group
12
UBS Group
Switzerland
-$3K -300 Closed